{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:40:43Z","timestamp":1790710843270,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":149,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068618"],"award-info":[{"award-number":["UM1AI068618"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["860064"],"award-info":[{"award-number":["860064"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P33510-B"],"award-info":[{"award-number":["P33510-B"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","award":["17614"],"award-info":[{"award-number":["17614"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004061","name":"Oesterreichische Nationalbank","doi-asserted-by":"publisher","award":["17633"],"award-info":[{"award-number":["17633"]}],"id":[{"id":"10.13039\/501100004061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaci.2021.03.038","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T20:41:18Z","timestamp":1618951278000},"page":"2083-2097.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2\u2013infected primary human airway epithelia"],"prefix":"10.1016","volume":"147","author":[{"given":"Wilfried","family":"Posch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Vosper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Noureen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Zaderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Witting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bertacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Gstir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemyslaw A.","family":"Filipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnther K.","family":"Bonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas A.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Bellmann-Weiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5888-5118","authenticated-orcid":false,"given":"Doris","family":"Wilflingseder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.03.038_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198070","article-title":"COVID-19: review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking","volume":"286","author":"Magro","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.jaci.2021.03.038_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.03.038_bib3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaci.2021.03.038_bib4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2021.03.038_bib5","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunologic features in severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2021.03.038_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.03.038_bib7","doi-asserted-by":"crossref","unstructured":"Jodele S, Kohl J. Tackling COVID-19 infection through complement-targeted immunotherapy [published online ahead of print July 9, 2020]. Br J Pharmacol. https:\/\/doi.org\/10.1111\/bph.15187.","DOI":"10.1111\/bph.15187"},{"key":"10.1016\/j.jaci.2021.03.038_bib8","doi-asserted-by":"crossref","unstructured":"Yan B, Freiwald T, Chauss D, Wang L, West E, Bibby J, et\u00a0al. SARS-CoV2 drives JAK1\/2-dependent local and systemic complement hyper-activation [published online ahead of print June 9, 2020]. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-33390\/v1.","DOI":"10.21203\/rs.3.rs-33390\/v1"},{"key":"10.1016\/j.jaci.2021.03.038_bib9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/s41591-020-1021-2","article-title":"Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection","volume":"26","author":"Ramlall","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2021.03.038_bib10","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/cells8101292","article-title":"Turning the world upside-down in cellulose for improved culturing and imaging of respiratory challenges within a human 3D model","volume":"8","author":"Zaderer","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2021.03.038_bib11","doi-asserted-by":"crossref","first-page":"11644","DOI":"10.1038\/s41598-017-11271-4","article-title":"Fast-track development of an in\u00a0vitro 3D lung\/immune cell model to study Aspergillus infections","volume":"7","author":"Chandorkar","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2021.03.038_bib12","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018100300","article-title":"Long-term expanding human airway organoids for disease modeling","volume":"38","author":"Sachs","year":"2019","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2021.03.038_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107588","article-title":"Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine","volume":"31","author":"Dijkstra","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2021.03.038_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009130","article-title":"Infection of human nasal epithelial cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles","volume":"16","author":"Gamage","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jaci.2021.03.038_bib15","doi-asserted-by":"crossref","first-page":"6822","DOI":"10.1073\/pnas.1806308115","article-title":"Differentiated human airway organoids to assess infectivity of emerging influenza virus","volume":"115","author":"Zhou","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2021.03.038_bib16","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.1073\/pnas.2002589117","article-title":"Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells","volume":"117","author":"Matsuyama","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2021.03.038_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-3083.1985.tb01870.x","article-title":"Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma","volume":"22","author":"Mollnes","year":"1985","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2021.03.038_bib18","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1038\/s41467-020-17796-z","article-title":"Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells","volume":"11","author":"Zhu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2021.03.038_bib19","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1128\/JVI.03368-12","article-title":"Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism","volume":"87","author":"Dijkman","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2021.03.038_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virusres.2007.03.013","article-title":"SARS-CoV replication and pathogenesis in an in\u00a0vitro model of the human conducting airway epithelium","volume":"133","author":"Sims","year":"2008","journal-title":"Virus Res"},{"key":"10.1016\/j.jaci.2021.03.038_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ncb1682","article-title":"Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission","volume":"10","author":"Sowinski","year":"2008","journal-title":"Nature Cell Biol"},{"key":"10.1016\/j.jaci.2021.03.038_bib22","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106267","article-title":"Syncytia formation by SARS-CoV-2-infected cells","volume":"39","author":"Buchrieser","year":"2020","journal-title":"EMBO J"},{"key":"10.1016\/j.jaci.2021.03.038_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103104","article-title":"Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology","volume":"61","author":"Bussani","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaci.2021.03.038_bib24","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1096\/fj.201500044","article-title":"Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis","volume":"30","author":"Gu","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2021.03.038_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis","volume":"588","author":"Carvelli","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2021.03.038_bib26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.virol.2010.12.045","article-title":"Complement and viral pathogenesis","volume":"411","author":"Stoermer","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.jaci.2021.03.038_bib27","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.03.038_bib28","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1096\/fj.13-247650","article-title":"Crosstalk between TGF-beta 1 and complement activation augments epithelial injury in pulmonary fibrosis","volume":"28","author":"Gu","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2021.03.038_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.jaci.2021.03.038_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.molimm.2015.07.030","article-title":"Parallel activities and interactions between antimicrobial peptides and complement in host defense at the airway epithelial surface","volume":"68","author":"Hiemstra","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2021.03.038_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaci.2020.04.027","article-title":"Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19","volume":"146","author":"Yang","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.03.038_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/CVI.00636-12","article-title":"Targeting the \u201ccytokine storm\u201d for therapeutic benefit","volume":"20","author":"D\u2019Elia","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jaci.2021.03.038_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2017.05.019","article-title":"Novel insights into the expression pattern of anaphylatoxin receptors in mice and men","volume":"89","author":"Laumonnier","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2021.03.038_bib34","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1182\/blood.V76.8.1631.1631","article-title":"Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself","volume":"76","author":"Schindler","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.03.038_bib35","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1096\/fj.09-133694","article-title":"Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells","volume":"23","author":"Sun","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2021.03.038_bib36","first-page":"651","article-title":"Activation of the complement system in the adult respiratory distress syndrome","volume":"135","author":"Robbins","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2021.03.038_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/science.aad1210","article-title":"T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells","volume":"352","author":"Arbore","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.03.038_bib38","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molimm.2017.05.012","article-title":"Intracellular complement\u2014the complosome\u2014in immune cell regulation","volume":"89","author":"Arbore","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2021.03.038_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2164-13-82","article-title":"RNA-Seq quantification of the human small airway epithelium transcriptome","volume":"13","author":"Hackett","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.jaci.2021.03.038_bib40","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.4049\/jimmunol.166.3.2025","article-title":"Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma","volume":"166","author":"Drouin","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.03.038_bib41","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jaci.2017.11.046","article-title":"The complement system in the airway epithelium: an overlooked host defense mechanism and therapeutic target?","volume":"141","author":"Kulkarni","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.03.038_bib42","doi-asserted-by":"crossref","first-page":"11123","DOI":"10.1074\/jbc.M206169200","article-title":"The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77\/acylation-stimulating protein","volume":"278","author":"Kalant","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2021.03.038_bib43","doi-asserted-by":"crossref","first-page":"23936","DOI":"10.1074\/jbc.M406921200","article-title":"C5L2 is a functional receptor for acylation-stimulating protein","volume":"280","author":"Kalant","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2021.03.038_bib44","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.molimm.2009.08.013","article-title":"Recombinant C3adesArg\/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation","volume":"46","author":"Cui","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaci.2021.03.038_bib45","article-title":"The controversial C5a receptor C5aR2: its role in health and disease","volume":"2017","author":"Zhang","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2021.03.038_bib46","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.1900371","article-title":"The complement receptor C5aR2: a powerful modulator of innate and adaptive immunity","volume":"202","author":"Li","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2021.03.038_bib47","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.imbio.2012.08.204","article-title":"Role of complement in modulation of TH2 response in prostate cancer cells","volume":"217","author":"Yamamoto","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaci.2021.03.038_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2021.03.038_bib49","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real\u00a0life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jaci.2021.03.038_bib50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41573-019-0031-6","article-title":"Clinical promise of next-generation complement therapeutics","volume":"18","author":"Mastellos","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2021.03.038_bib51","article-title":"Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation","author":"Gao","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jaci.2021.03.038_bib52","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.jaip.2020.04.014","article-title":"Weathering the cytokine storm in susceptible patients with severe SARS-CoV-2 infection","volume":"8","author":"Lipworth","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.03.038_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921005601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921005601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:32:27Z","timestamp":1758792747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921005601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0091674921005601"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.03.038","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2\u2013infected primary human airway epithelia","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}